2011

1. James MT, Ghali WA, Knudtson ML, Ravani P, Tonelli M, Faris P, Pannu N, Manns BJ, Klarenbach SW, Hemmelgarn BR. Associations between acute kidney injury, cardiovascular and renal outcomes after coronary angiography. Circulation 2011;123:409-416.

2. Tonelli M, Muntner P, Lloyd A, Manns BJ, James MT, Klarenbach S, Quinn RR, Wiebe N, Hemmelgarn BR. Using proteinuria and estimated glomerular filtration rate to classify risk in people with chronic kidney disease. Ann Intern Med 2011;154:12-21.

3. Clement FM, James MT, Chin R, Klarenbach SW, Manns BJ, Quinn RR, Ravani P, Tonelli M, Hemmelgarn BR. Validation of a case definition to define chronic dialysis using outpatient administrative data. BMC Medical Research Methodology 2011;11:25.

4. Pannu N, James M, Hemmelgarn BR, Dong J, Tonelli M, Klarenbach S. Modification of Outcomes After Acute Kidney Injury by the Presence of CKD. Am J Kidney Dis. 2011;58:206-213.

5. Bello AK, Hemmelgarn BR, Lloyd A, James MT, Manns BJ, Klarenbach S, Tonelli M. Associations between estimated glomerular filtration rate, proteinuria and adverse cardiovascular outcomes. Clin J Am Soc Nephrol 2011;6:1418-1426.

6. Tonelli M, Klarenbach SW, Lloyd A, James MT, Bello A, Manns BJ, Hemmelgarn BR. Association between estimated glomerular filtration rate and adverse clinical outcomes. Kidney Int 2011 in press.

7. Ayyalasomayajula B, Wiebe N, Hemmelgarn BR, Bello A, Manns B, Klarenbach S, Tonelli M. A novel technique to optimize facility locations of new nephrology services for remote areas. Clin J Am Soc Nephrol 2011. Sep;6(9):2157-64. Epub 2011 Aug 4.

2010

1.Tai DJ, Lim TW, James MT, Manns BJ, Tonelli M, Hemmelgarn BR; for the Alberta Kidney Disease Network.  Cardiovascular Effects of Angiotensin Converting Enzyme Inhibition or Angiotensin Receptor Blockade in Hemodialysis: A Meta-Analysis.. Clin J Am Soc Nephrol. 2010 Feb 4.

2. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M; Alberta Kidney Disease Network. Relation between kidney function, proteinuria, and adverse outcomes. JAMA. 2010 Feb 3;303(5):423-9.

3. Al-Ghamdi G, Hemmelgarn B, Klarenbach S, Manns B, Wiebe N, Tonelli M; Alberta Kidney Disease Network. Dialysate potassium and risk of death in chronic hemodialysis patients. J Nephrol. 2010 Jan-Feb;23(1):33-40.

2009

1. Barnieh L, McLaughlin K, Manns B, Klarenbach S, Yilmaz S, Hemmelgarn B; Alberta Kidney Disease Network. Development of a survey to identify barriers to living donation in kidney transplant candidates. Prog Transplant. 2009 Dec;19(4):304-11.

2. Hemmelgarn BR, Clement F, Manns BJ, Klarenbach S, James MT, Ravani P, Pannu N, Ahmed SB, MacRae J, Scott-Douglas N, Jindal K, Quinn R, Culleton BF, Wiebe N, Krause R, Thorlacius L, Tonelli M. Overview of the Alberta Kidney Disease Network. BMC Nephrol. 2009 Oct 19;10:30.

3. Deved V, Poyah P, James MT, Tonelli M, Manns BJ, Walsh M, Hemmelgarn BR; Alberta Kidney Disease Network. Ascorbic acid for anemia management in hemodialysis patients: a systematic review and meta-analysis. Am J Kidney Dis. 2009 Dec;54(6):1089-97. Epub 2009 Sep 23.

4. James MT, Manns BJ, Hemmelgarn BR, Ravani P; Alberta Kidney Disease Network. What's next after fistula first: is an arteriovenous graft or central venous catheter preferable when an arteriovenous fistula is not possible? Semin Dial. 2009 Sep-Oct;22(5):539-44. Epub 2009 Sep 9. Review.

5. Tonelli M, Wang W, Hemmelgarn B, Lloyd A, Manns B; Alberta Kidney Disease Network. Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients.  Am J Kidney Dis. 2009 Dec;54(6):1108-15. Epub 2009 Jul 19.

6. Klarenbach S, Manns B, Pannu N, Clement FM, Wiebe N, Tonelli M; Alberta Kidney Disease Network. Economic evaluation of continuous renal replacement therapy in acute renal failure. Int J Technol Assess Health Care. 2009 Jul;25(3):331-8

7. Tonelli M, Wiebe N, Hemmelgarn B, Klarenbach S, Field C, Manns B, Thadhani R, Gill J; Alberta Kidney Disease Network. Trace elements in hemodialysis patients: a systematic review and meta-analysis. BMC Med. 2009 May 19;7:25.

8. James MT, Quan H, Tonelli M, Manns BJ, Faris P, Laupland KB, Hemmelgarn BR; Alberta Kidney Disease Network. CKD and risk of hospitalization and death with pneumonia. Am J Kidney Dis. 2009 Jul;54(1):24-32. Epub 2009 May 17.

2008

1. Manns BJ, Walsh MW, Culleton BF, Hemmelgarn B, Tonelli M, Schorr M, Klarenbach S; Alberta Kidney Disease Network. Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. Kidney Int. 2009 Mar;75(5):542-9. Epub 2008 Dec 24.

2. James MT, Laupland KB, Tonelli M, Manns BJ, Culleton BF, Hemmelgarn BR; Alberta Kidney Disease Network. Risk of bloodstream infection in patients with chronic kidney disease not treated with dialysis. Arch Intern Med. 2008 Nov 24;168(21):2333-9.

3. Gao S, Manns BJ, Culleton BF, Tonelli M, Quan H, Crowshoe L, Ghali WA, Svenson LW, Ahmed S, Hemmelgarn BR; Alberta Kidney Disease Network. Access to health care among status Aboriginal people with chronic kidney disease. CMAJ. 2008 Nov 4;179(10):1007-12.

4. Ahmed SB, Culleton BF, Tonelli M, Klarenbach SW, Macrae JM, Zhang J, Hemmelgarn BR; Alberta Kidney Disease Network. Oral estrogen therapy in postmenopausal women is associated with loss of kidney function. Kidney Int. 2008 Aug;74(3):370-6. Epub 2008 May 21.

5. Wang W, Tonelli M, Hemmelgarn B, Gao S, Johnson JA, Taub K, Manns B; Alberta Kidney Disease Network. The effect of increasing dialysis dose in overweight hemodialysis patients on quality of life: a 6-week randomized crossover trial. Am J Kidney Dis. 2008 May;51(5):796-803

6. James MT, Conley J, Tonelli M, Manns BJ, MacRae J, Hemmelgarn BR; Alberta Kidney Disease Network.Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections.  Ann Intern Med. 2008 Apr 15;148(8):596-605.

7. Tonelli M, James M, Wiebe N, Jindal K, Hemmelgarn B; Alberta Kidney Disease Network. Ultrasound monitoring to detect access stenosis in hemodialysis patients: a systematic review. Am J Kidney Dis. 2008 Apr;51(4):630-40.

8. Pannu N, Klarenbach S, Wiebe N, Manns B, Tonelli M; Alberta Kidney Disease Network.
Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA. 2008 Feb 20;299(7):793-805.

9. Al-Ghonaim M, Manns BJ, Hirsch DJ, Gao Z, Tonelli M; Alberta Kidney Disease Network.
Relation between access blood flow and mortality in chronic hemodialysis patients.
Clin J Am Soc Nephrol. 2008 Mar;3(2):387-91.

2007

1. Tonelli M, Manns B, Culleton B, Klarenbach S, Hemmelgarn B, Wiebe N, Gill JS; Alberta Kidney Disease Network. Association between proximity to the attending nephrologist and mortality among patients receiving hemodialysis. CMAJ. 2007 Oct 23;177(9):1039-44

2. Gao S, Manns BJ, Culleton BF, Tonelli M, Quan H, Crowshoe L, Ghali WA, Svenson LW, Hemmelgarn BR; Alberta Kidney Disease Network. Prevalence of chronic kidney disease and survival among aboriginal people. J Am Soc Nephrol. 2007 Nov;18(11):2953-9.

3. Tonelli M, Wiebe N, Culleton B, Lee H, Klarenbach S, Shrive F, Manns B; Alberta Kidney Disease Network. Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients. Nephrol Dial Transplant. 2007 Oct;22(10):2856-66.

4. Chou SH, Tonelli M, Bradley JS, Gourishankar S, Hemmelgarn BR; Alberta Kidney Disease Network. Quality of care among Aboriginal hemodialysis patients. Clin J Am Soc Nephrol. 2006 Jan;1(1):58-63

5. Thomas CM, Zhang J, Lim TH, Scott-Douglas N, Hons RB, Hemmelgarn BR; Alberta Kidney Disease Network. Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction. ASAIO J. 2007 Jul-Aug;53(4):485-8.

6. Tonelli M, Hemmelgarn B, Culleton B, Klarenbach S, Gill JS, Wiebe N, Manns B; Alberta Kidney Disease Network. Mortality of Canadians treated by peritoneal dialysis in remote locations. Kidney Int. 2007 Oct;72(8):1023-8.

7. Tonelli M, Hemmelgarn B, Gill JS, Chou S, Culleton B, Klarenbach S, Manns B, Wiebe N, Gourishankar S; Alberta Kidney Disease Network. Patient and allograft survival of Indo Asian and East Asian dialysis patients treated in Canada. Kidney Int. 2007 Aug;72(4):499-504. >

8. Tonelli M, Klarenbach S, Manns B, Culleton B, Hemmelgarn B, Bertazzon S, Wiebe N, Gill JS; Alberta Kidney Disease Network. Residence location and likelihood of kidney transplantation. CMAJ. 2006 Aug 29;175(5):478-82.

9. Tonelli M, Hemmelgarn B, Kim AK, Bertazzon S, Klarenbach S, Manns B, Wiebe N, Culleton B, Gill JS; Alberta Kidney Disease Network. Association between residence location and likelihood of kidney transplantation in Aboriginal patients treated with dialysis in Canada. Kidney Int. 2006 Sep;70(5):924-30.

10. Pannu N, Wiebe N, Tonelli M; Alberta Kidney Disease Network. Prophylaxis strategies for contrast-induced nephropathy. JAMA. 2006 Jun 21;295(23):2765-79.

11. Tonelli M, Klarenbach S, Jindal K, Manns B; Alberta Kidney Disease Network Economic implications of screening strategies in arteriovenous fistulae. Kidney Int. 2006 Jun;69(12):2219-26.

12. Tonelli M, Chou S, Gourishankar S, Jhangri GS, Bradley J, Hemmelgarn B; Alberta Kidney Disease Network. Wait-listing for kidney transplantation among Aboriginal hemodialysis patients. Am J Kidney Dis. 2005 Dec;46(6):1117-23.